Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 170 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population

 		Hidradenitis Suppurativa Italy NCT07543419

REAL-CARE: Real-world Effectiveness of Iptacopan in Italian Patients With Paroxysmal Nocturnal Hemoglobinuria

 		Paroxysmal Nocturnal Hemoglobinuria (PNH) Italy NCT07229235

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

 		Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF) Phase3 South Korea NCT07357727

A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction

 		Heart Failure With Reduced Ejection Fraction Phase1 United States NCT07465653

Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction

 		Plaque, Atherosclerotic Phase4 China NCT06372925

A Non-Interventional Study PASS to Characterize Secondary Malignancies of Tcell Origin Following Tisagenlecleucel Therapy

 		Secondary Malignancies of T-cell Origin Japan NCT07378969

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

 		Cardiovascular Disease and Lipoprotein(a) Phase3 Argentina
Belgium
Brazil
Colombia
Czechia
Germany
India
Israel
Italy
Netherlands
Romania
Slovakia
Spain
Switzerland
Turkey (Türkiye)
United Kingdom
United States
View all
 NCT07517263

Real-World Treatment Pattern and Clinical Outcome With Influential Factors of HR+/HER2-aBC 1L Patients in China

 		HR+/HER2- Advanced or Metastatic Breast Cancer China NCT07476170

Impact of Implementation Strategies on Lp(a) Testing in Secondary Care Settings

 		Implementing EAS/ESC Guideline Recommendation on Lp(a) Testing in Routine Practice Germany NCT07508007

Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China

 		Chronic Myeloid Leukemia in Chronic Phase China NCT07375355